{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:06:34Z","timestamp":1790957194118,"version":"4.1.0"},"reference-count":41,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>With the aging of the population and projected increase in osteoporotic fractures coupled with the declining use of osteoporosis medications, there is a compelling need for new approaches to treat osteoporosis. Given that age-related osteoporosis generally coexists with multiple other comorbidities (e.g., atherosclerosis, diabetes, frailty) that share aging as the leading risk factor, there is growing interest in the \u201cGeroscience Hypothesis,\u201d which posits that manipulation of fundamental aging mechanisms will delay the appearance or severity of multiple chronic diseases because these diseases share aging as the underlying risk factor. In this context, one fundamental aging mechanism that has received considerable attention recently as contributing to multiple age-related morbidities is cellular senescence. This mini-review provides an overview on cellular senescence with a focus on its role in mediating age-related bone loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This summary is based on the authors\u2019 knowledge of the field supplemented by a PubMed search using the terms \u201csenescence,\u201d \u201caging,\u201d and \u201cbone.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There is compelling evidence from preclinical models and supportive human data demonstrating an increase in senescent cells in the bone microenvironment with aging. These cells produce a proinflammatory secretome that leads to increased bone resorption and decreased bone formation, and approaches that either eliminate senescent cells or impair the production of their proinflammatory secretome have been shown to prevent age-related bone loss in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Targeting cellular senescence represents a novel therapeutic strategy to prevent not only bone loss but potentially multiple age-related diseases simultaneously.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jc.2017-02694","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T14:06:26Z","timestamp":1518012386000},"page":"1282-1290","source":"Crossref","is-referenced-by-count":124,"title":["Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis"],"prefix":"10.1210","volume":"103","author":[{"given":"Sundeep","family":"Khosla","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism and Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua N","family":"Farr","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism and Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L","family":"Kirkland","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism and Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"issue":"12","key":"2020071623080065200_B1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"issue":"5","key":"2020071623080065200_B2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00004148","article-title":"World-wide projections for hip fracture","volume":"7","author":"Gullberg","year":"1997","journal-title":"Osteoporos Int"},{"issue":"12","key":"2020071623080065200_B3","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-008-0634-y","article-title":"Incidence of fractures compared to cardiovascular disease and breast cancer: the Women\u2019s Health Initiative Observational Study","volume":"19","author":"Cauley","year":"2008","journal-title":"Osteoporos Int"},{"issue":"13","key":"2020071623080065200_B4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"issue":"7","key":"2020071623080065200_B5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators: mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"2020071623080065200_B6","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071623080065200_B7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr Rev"},{"issue":"19","key":"2020071623080065200_B8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"2020071623080065200_B9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs. placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"2020071623080065200_B10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jbmr.2832","article-title":"Impact of the U.S. Food and Drug Administration\u2019s safety-related announcements on the use of bisphosphonates after hip fracture","volume":"31","author":"Kim","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2020071623080065200_B11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2020071623080065200_B12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","article-title":"Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)","volume":"50","author":"Dennison","year":"2012","journal-title":"Bone"},{"issue":"2","key":"2020071623080065200_B13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cger.2017.01.007","article-title":"Polypharmacy reduction strategies: tips on incorporating American Geriatrics Society Beers and Screening Tool of older people\u2019s prescriptions criteria","volume":"33","author":"Levy","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"2020071623080065200_B14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J Clin Invest"},{"issue":"10","key":"2020071623080065200_B15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tem.2017.07.004","article-title":"Molecular mechanisms determining lifespan in short- and long-lived species","volume":"28","author":"Tian","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2020071623080065200_B16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"issue":"3","key":"2020071623080065200_B17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","article-title":"The limited in vitro lifetime of human diploid cell strains","volume":"37","author":"Hayflick","year":"1965","journal-title":"Exp Cell Res"},{"key":"2020071623080065200_B18","first-page":"9.51.1","article-title":"Quantitative analysis of cellular senescence in culture and in vivo","volume":"79","author":"Zhao","year":"2017","journal-title":"Curr Protoc Cytom"},{"issue":"6","key":"2020071623080065200_B19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1083\/jcb.201306073","article-title":"Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence","volume":"203","author":"Swanson","year":"2013","journal-title":"J Cell Biol"},{"issue":"5765","key":"2020071623080065200_B20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1126\/science.1122446","article-title":"Cellular senescence in aging primates","volume":"311","author":"Herbig","year":"2006","journal-title":"Science"},{"issue":"7372","key":"2020071623080065200_B21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2020071623080065200_B22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"issue":"20","key":"2020071623080065200_B23","doi-asserted-by":"crossref","first-page":"e90220","DOI":"10.1172\/jci.insight.90220","article-title":"Low-dose dasatinib rescues cardiac function in Noonan syndrome","volume":"1","author":"Yi","year":"2016","journal-title":"JCI Insight"},{"key":"2020071623080065200_B24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","article-title":"Quercetin: a flavonol with multifaceted therapeutic applications","volume":"106","author":"D\u2019Andrea","year":"2015","journal-title":"Fitoterapia"},{"key":"2020071623080065200_B25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","article-title":"Cellular senescence: a translational perspective","volume":"21","author":"Kirkland","year":"2017","journal-title":"EBioMedicine"},{"issue":"11","key":"2020071623080065200_B26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/jbmr.2892","article-title":"Identification of senescent cells in the bone microenvironment","volume":"31","author":"Farr","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"17","key":"2020071623080065200_B27","doi-asserted-by":"crossref","first-page":"93771","DOI":"10.1172\/jci.insight.93771","article-title":"Old age causes de novo intracortical bone remodeling and porosity in mice","volume":"2","author":"Piemontese","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"2020071623080065200_B28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/acel.12597","article-title":"DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age","volume":"16","author":"Kim","year":"2017","journal-title":"Aging Cell"},{"issue":"9","key":"2020071623080065200_B29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4385","article-title":"Targeting cellular senescence prevents age-related bone loss in mice","volume":"23","author":"Farr","year":"2017","journal-title":"Nat Med"},{"key":"2020071623080065200_B30","doi-asserted-by":"crossref","first-page":"e12997","DOI":"10.7554\/eLife.12997","article-title":"Targeting senescent cells enhances adipogenesis and metabolic function in old age","volume":"4","author":"Xu","year":"2015","journal-title":"eLife"},{"issue":"46","key":"2020071623080065200_B31","doi-asserted-by":"crossref","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2020071623080065200_B32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jbmr.1541","article-title":"Odanacatib: location and timing are everything","volume":"27","author":"Khosla","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2020071623080065200_B33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/acel.12458","article-title":"Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice","volume":"15","author":"Roos","year":"2016","journal-title":"Aging Cell"},{"issue":"6311","key":"2020071623080065200_B34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.aaf6659","article-title":"Senescent intimal foam cells are deleterious at all stages of atherosclerosis","volume":"354","author":"Childs","year":"2016","journal-title":"Science"},{"issue":"10","key":"2020071623080065200_B35","first-page":"669","article-title":"Merck & Co. drops osteoporosis drug odanacatib","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"2020071623080065200_B36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2017.136","article-title":"Bone diseases: Romosozumab - on track or derailed","volume":"13","author":"Khosla","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"2020071623080065200_B37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2020071623080065200_B38","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","article-title":"Programmed cell senescence during mammalian embryonic development","volume":"155","author":"Mu\u00f1oz-Esp\u00edn","year":"2013","journal-title":"Cell"},{"issue":"5","key":"2020071623080065200_B39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2013.10.041","article-title":"Senescence is a developmental mechanism that contributes to embryonic growth and patterning","volume":"155","author":"Storer","year":"2013","journal-title":"Cell"},{"issue":"1","key":"2020071623080065200_B40","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-017-01509-0","article-title":"Programmed cell senescence in skeleton during late puberty","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"2020071623080065200_B41","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","article-title":"An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA","volume":"31","author":"Demaria","year":"2014","journal-title":"Dev Cell"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1282\/25088703\/jc.2017-02694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1282\/25088703\/jc.2017-02694.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T07:51:27Z","timestamp":1594972287000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/4\/1282\/4841935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02694","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,2,7]]}}}